Home
Ology Bioservices, Inc.

Ology Bioservices, Inc. Market Share Analysis for February 2026

we're changing the way medicine is made - leveraging innovation to better serve scientific discovery, withstand disruptive events, and reach those in need.

Health > Biotechnology and Pharmaceuticals

Domainologybio.com

Year Founded1999

Employees201 - 500

Annual Revenue$25M - $50M

Ology Bioservices, Inc.

Ology Bioservices, Inc. (including company regionals)

ologybio.com

See more website traffic and engagement information

Ology Bioservices, Inc. Revenue up to February 2026 is 25M - 50M

revenue generated by Ology Bioservices, Inc. top domains

Ology Bioservices, Inc. top domains revenue over 3 years

Revenue for Ology Bioservices, Inc. top domains

ologybio.com25M - 50M

See more with Sales Intelligence

Total visits to Ology Bioservices, Inc.'s top domains

Understand Ology Bioservices, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Ology Bioservices, Inc.'s top domains

Analyze Ology Bioservices, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Ology Bioservices, Inc.'s top domains

See how Ology Bioservices, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Ology Bioservices, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Ology Bioservices, Inc.

These are the website technologies, by industry, used by Ology Bioservices, Inc. top domains

Payment & Currencies (7)

Cart Functionality

Social (4)

Instagram

Widget (4)

Twemoji

Audio Video Media (2)

YouTube

More Technologies

7

See all

News & Signals from Ology Bioservices, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsResilience Council acquired Ologybio on Apr 1st '21.And in April 2021, Resilience acquired Ology Bioservices and bagged itself a facility in Florida.

NewsOlogybio is developing monoclonal antibodies against botulinum neurotoxins.Ology Bioservices of the city of Alachua were selected to develop monoclonal antibodies against botulinum neurotoxins.

NewsOlogybio is developing monoclonal antibody on Feb 10th '22.Resilience subsidiary Ology Bioservices has been awarded a $250 million contract by the US DOD to develop a monoclonal antibody as a medical countermeasure to botulinum neurotoxins.